PAR2 inhibitor (Tufts Medical Center)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePAR2 inhibitor (Tufts Medical Center)
Drug Alias Nameproteinase-activated receptor 2 inhibitor (Tufts Medical Center)P2pal-18S pepducin (Tufts Medical Center)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsSkin DiseasesHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTufts Medical Center Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTufts Medical Center Inc
Active IndicationsN/A
Inactive IndicationsSkin DiseasesHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A